Genetics of Psychosis in Alzheimer Disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Genetic Medicine Reports

• Publication date

  2014-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s40142-014-0030-1PMID 24883238PMCID PMC4034371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Psychosis in Alzheimer's disease.

  2014cited by this paper
• The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.

  2013cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

  2013cited by this paper
• 2013 Alzheimer's disease facts and figures

  2013cited by this paper
• CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease

  2012cited by this paper
• Genome-wide association study of Alzheimer's disease

  2012cited by this paper
• Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study

  2012cited by this paper
• Psychosis in Alzheimer's Disease in the National Alzheimer's Disease Coordinating Center Uniform Data Set: Clinical Correlates and Association with Apolipoprotein E

  2011cited by this paper
• Visinin‐like protein‐1: Diagnostic and prognostic biomarker in Alzheimer disease

  2011cited by this paper
• Genome-wide Association Study of Alzheimer’s disease with Psychotic Symptoms

  2011cited by this paper
• Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder.

  2011cited by this paper
• No association of psychosis in Alzheimer disease with neurodegenerative pathway genes.

  2011cited by this paper
• TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease.

  2011cited by this paper
• Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE

  2011cited by this paper
• Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study.

  2010cited by this paper
• Genetics of Psychosis in Alzheimer's Disease: A Review

  2010cited by this paper
• Genetic copy number variants in sib pairs both affected with schizophrenia

  2010cited by this paper
• Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease

  2009cited by this paper
• Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain

  2009cited by this paper
• Brain traffic: subcellular transport of the amyloid precursor protein.

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Neuronal calcium sensors and synaptic plasticity.

  2009influential reference
• Genetics of psychosis; insights from views across the genome

  2009cited by this paper
• Meta-analysis of genome-wide association data detects a risk locus for major mood disorders on chromosome 3p21.1

  2009cited by this paper
• Common variants on chromosome 6p22.1 are associated with schizophrenia

  2009cited by this paper
• Common variants conferring risk of schizophrenia

  2009cited by this paper
• A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease

  2009cited by this paper
• Dysregulation of miRNA 181b in the temporal cortex in schizophrenia.

  2008cited by this paper
• P3‐209: Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease

  2008cited by this paper
• The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients.

  2008cited by this paper
• Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease.

  2008cited by this paper
• Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder

  2008cited by this paper
• Identification of loci associated with schizophrenia by genome-wide association and follow-up

  2008cited by this paper
• Aβ Oligomers – a decade of discovery

  2007influential reference
• The β-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy*

  2007cited by this paper
• Suppression of Tubulin Polymerization by the LKB1-Microtubule-associated Protein/Microtubule Affinity-regulating Kinase Signaling*

  2007cited by this paper
• Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis

  2007cited by this paper
• Activation of PAR-1 Kinase and Stimulation of Tau Phosphorylation by Diverse Signals Require the Tumor Suppressor Protein LKB1

  2007cited by this paper
• The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

  2007cited by this paper
• Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology.

  2006cited by this paper
• Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

  2006cited by this paper
• Peutz-Jeghers Syndrome Diagnosed in a Schizophrenic Patient with a Large Deletion in the STK11 Gene

  2006cited by this paper
• Hallucinations and mortality in Alzheimer disease.

  2005cited by this paper
• Heritability of psychosis in Alzheimer disease.

  2005cited by this paper
• Neuregulin‐1 polymorphism in late onset Alzheimer's disease families with psychoses

  2005cited by this paper
• Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms

  2005cited by this paper
• The interleukin 1β gene promoter polymorphism (−511) acts as a risk factor for psychosis in Alzheimer's dementia

  2004cited by this paper
• The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia.

  2004cited by this paper
• Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies.

  2003cited by this paper
• Alzheimer's Disease Is a Synaptic Failure

  2002cited by this paper
• Neuregulin 1 and susceptibility to schizophrenia.

  2002cited by this paper
• Linkage analysis of Alzheimer disease with psychosis

  2002cited by this paper
• A highly significant association between a COMT haplotype and schizophrenia.

  2002cited by this paper
• Increased familial risk of the psychotic phenotype of Alzheimer disease

  2002cited by this paper
• Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology.

  2002cited by this paper
• Hippocampal expression of the calcium sensor protein visinin-like protein-1 in schizophrenia

  2002cited by this paper
• Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7).

  2001cited by this paper
• The 5-HTTPR Polymorphism Confers Liability to a Combined Phenotype of Psychotic and Aggressive Behavior in Alzheimer Disease

  2001cited by this paper
• Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

  2000cited by this paper
• Familial influence on variation in age of onset and behavioural phenotype in Alzheimer's disease.

  2000cited by this paper
• Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates

  2000cited by this paper
• Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

  1999cited by this paper
• Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.

  1999cited by this paper
• Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease

  1999cited by this paper
• Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

  1999cited by this paper
• Assessing the Impact of Neuropsychiatric Symptoms in Alzheimer's Disease: The Neuropsychiatric Inventory Caregiver Distress Scale

  1998cited by this paper
• Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging

  1998cited by this paper
• Psychotic Symptoms and Physically Aggressive Behavior in Alzheimer's Disease

  1997cited by this paper
• Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.

  1997cited by this paper
• Risk of Mortality and Institutionalization in Demented Patients with Delusions

  1996cited by this paper
• Neuropsychiatric Syndromes in Neurodegenerative Disease: Frequency and Signficance.

  1996cited by this paper
• Altered serotonin transporter sites in Alzheimer's disease raphe and hippocampus

  1995cited by this paper
• Genetics of psychosis

  1995cited by this paper
• Altered serotonin transporter sites in Alzheimer's disease raphe and hippocampus.

  1995cited by this paper
• Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.

  1992cited by this paper
• Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Hallucinations and associated factors in Alzheimer's disease.

  1991cited by this paper
• Serotonin in Alzheimer‐type Dementia and Other Dementing Illnesses

  1990cited by this paper
• A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia

  1990cited by this paper
• Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type.

  1989cited by this paper
• Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

  1983cited by this paper
• The impact of dementia on the family.

  1982cited by this paper
• Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology Neurobiology of Neuregulin 1

  year unknowncited by this paper

• Compensatory Plasticity Defines a Vulnerable Neuronal State in Alzheimer’s Disease with Psychosis

  2025cites this paper
• GWAS links APOE to neuropsychiatric symptoms in mild cognitive impairment and dementia

  2025cites this paper
• Behavioral and Psychological Symptoms (BPSD) in Alzheimer's Disease (AD): Development and Treatment.

  2025cites this paper
• A longitudinal study of late-life psychosis and incident dementia and the potential effects of race and cognition

  2023cites this paper
• Does the APOE ε4 Allele Moderate a CA1 Atrophy and Psychotic Symptomatology Relationship in Alzheimer’s Disease?

  2023cites this paper
• Neuropsychiatric Symptoms of Alzheimer’s Disease: An Anatomic-Genetic Framework for Treatment Development

  2023cites this paper
• Alzheimer’s Disease and Role of Apolipoprotein E in Alzheimer’s Disease

  2022cites this paper
• Five Major Psychiatric Disorders and Alzheimer’s Disease: A Bidirectional Mendelian Randomization Study

  2022cites this paper
• The Role of Decreased Cortical Thickness and Volume of Medial Temporal Lobe Structures in Predicting Incident Psychosis in Patients With Alzheimer's Disease: A Prospective Longitudinal MRI Study.

  2021cites this paper
• A new approach for detection Alzheimer's Disease with machine learning using Whole Genomic and Single Nucleotide Polymorphism-Chip data

  2021cites this paper
• A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease

  2021influential citation
• Cortical complexity alterations in the medial temporal lobe are associated with Alzheimer’s disease psychosis

  2021cites this paper
• The Impact of Angiotensin-Converting Enzyme Gene on Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease.

  2020cites this paper
• Troubles du comportement chez les sujets âgés en Afrique Centrale

  2019cites this paper
• Synaptic proteome compensation and resilience to psychosis in Alzheimer Disease homogenate and postsynaptic density fractions from an APPswe/PSEN1dE9 mouse model of

  2018cites this paper
• Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease.

  2018cites this paper
• Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.

  2018cites this paper
• Mediation of insulin growth factor-1 in Alzheimer's disease and the mechanism of PRNP genetic expression and the PI3K/Akt signaling pathway

  2017cites this paper
• Psychosis in Dementia

  2017cites this paper
• Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer’s Disease

  2017cites this paper
• Psychosis in Alzheimer’s Disease: a Review of Recent Research Findings

  2016cites this paper
• A Bayesian model of psychosis symptom trajectory in Alzheimer's disease

  2016cites this paper
• Biomarkers of aggression in dementia.

  2016cites this paper
• Focus on psychosis

  2015cites this paper